On Invalid Date, Neuronetics (NASDAQ: STIM) reported Q4 2022 earnings per share (EPS) of -$0.30, up 7.14% year over year. Total Neuronetics earnings for the quarter were -$8.29 million. In the same quarter last year, Neuronetics's earnings per share (EPS) was -$0.28.
On Invalid Date, Neuronetics (NASDAQ: STIM) reported Q4 2022 revenue of $18.20 million up 21.14% year over year. In the same quarter last year, Neuronetics's revenue was $15.02 million.
What was STIM's revenue growth in the past year?
As of Q1 2023, Neuronetics's revenue has grown 17.89% year over year. This is 7.26 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 10.63%. Neuronetics's revenue in the past year totalled $65.21 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.